News

February 7, 2011 – A rare and often underreported form of stroke involving veins instead of arteries is more common than previously thought, according to the American Heart Association's (AHA) first scientific statement on diagnosing and managing cerebral venous thrombosis (CVT).

Home February 07, 2011
Home
News

February 7, 2011 – Final testing for a point-of-care blood analyzer will begin at four hospitals in North America. The QL Care (QLCA) analyzer, by CardioGenics, tests for troponin-I levels, and data will be used to file a 510(k) application with the U.S. Food and Drug Administration (FDA).

Home February 07, 2011
Home
News

February 4, 2011 – In the largest group of emergency department patients with atrial flutter studied to date, researchers found these patients may be substantially different from those described in the cardiology literature. The results of the study were published in the Annals of Emergency Medicine.

Home February 04, 2011
Home
News

February 4, 2011 – More heart disease tests do not necessarily add up to a better diagnosis. According to a new practice guideline, a basic risk assessment that accounts for such factors as cholesterol level, blood pressure, age, sex, family history, smoking and diabetes is still the strongest tool a doctor can use in predicting the likelihood of heart disease.

Home February 04, 2011
Home
Technology

February 4, 2011 – A new mobile radiology application cleared today by the U.S. Food and Drug Administration (FDA) will allow physicians to view and make a diagnosis from medical images on the Apple iPhone and iPad.

Home February 04, 2011
Home
News

February 4, 2011 – Researchers at the National Institutes of Health's (NIH) Undiagnosed Diseases Program (UDP) have identified the genetic cause of a rare and debilitating vascular disorder not previously explained in the medical literature.

Home February 04, 2011
Home
News

February 3, 2011 – Widespread screening or routine ultrasound for blocked neck arteries to determine stroke risk isn't necessary, according to new guidelines from the American Heart Association/American Stroke Association, American College of Cardiology and other groups.

Home February 03, 2011
Home
News

February 3, 2011 – Behrman Capital, a private equity investment firm based in New York and San Francisco, has acquired Atherotech, a cardiometabolic testing services provider. Atherotech offers the VAP (Vertical Auto Profile) advanced lipid profile test.

Home February 03, 2011
Home
News

February 1, 2011 – The U.S. Food and Drug Administration has approved a Phase I clinical trial to test a new technology for treating critical limb ischemia (CLI). The Investigational Device Exemption (IDE) allows Arteriocyte to test its Magellan MAR01 technology.

Home February 01, 2011
Home
News

February 1, 2011 – Despite the benefits of therapy with implantable cardioverter-defibrillators (ICDs), inappropriate shocks from the devices are common and place patients at a greater mortality risk. These were the conclusions drawn by a Dutch research team that examined the incidence, predictors and patient outcomes of inappropriate ICD shocks in a large, real-world patient population.

Home February 01, 2011
Home
News

January 31, 2011 – Volcano Corp. said today the Superior Court of Massachusetts issued a decision ruling in favor of Volcano and its subsidiary Axsun Technologies Inc., and against LightLab Imaging Inc., on all of LightLab's remaining claims for intravascular optical coherence tomography (OCT) trade secret misappropriation.

Home February 01, 2011
Home
News

February 1, 2011 – A self-anchoring aortic heart valve has received the CE mark. With the approval, the Perceval S Sutureless biological valve, by the Sorin Group, is now commercially available in Europe.

Home February 01, 2011
Home
News

January 31, 2011 – Parental history of heart disease nearly doubles a person’s risk in all regions of the world, even after considering all other known risk factors of heart disease. The results come from a study published in the Feb. 1, 2011, issue of the Journal of the American College of Cardiology.

Home January 31, 2011
Home
News

January 31, 2011 – The first successful transcatheter implantation of a 27 mm transapical aortic valve prosthesis has been completed. The procedure was performed by Hendrik Treede, M.D., at the University Heart Center Hamburg using JenaValve’s transcatheter aortic valve implantation (TAVI) system. It was part of the company’s ongoing pivotal CE mark trial

Home January 31, 2011
Home
Technology

January 31, 2011 – A new catheter used to treat coronary artery disease has received regulatory clearance in the United States and approval in Japan. The Trek and Mini-Trek systems, by Abbott, are used in angioplasty procedures and are designed to enable interventional cardiologists to open patients' narrowed coronary arteries. The Trek system received the CE mark in May 2010.

Home January 31, 2011
Home
Subscribe Now